UK Medtech's US Innovation Hub Aims To Accentuate The Positive In Post-Brexit Phase

With Brexit moving ever closer, the UK medtech industry is trying to ensure that local manufacturers have a range of commercial options in overseas markets in the post-EU phase. The ABHI is playing a strong support role in this area, following up its recent international growth plan with a new US innovation hub, designed to offer outward-looking UK medtechs the tools to build positions in the world's largest market.

More from Policy & Regulation

More from Medtech Insight